State Of Wyoming Pliant Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.01 - $14.1 $5,236 - $10,532	-747 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$12.27 - $18.26 $1,607 - $2,392	131 Added 21.27%	747 $10,000
Q3 2021 Feb 11, 2022	SELL	$16.48 - $28.98 $6,031 - $10,606	-366 Reduced 37.27%	616 $10,000
Q2 2021 Feb 11, 2022	BUY	$28.05 - $37.69 $16,044 - $21,558	572 Added 139.51%	982 $29,000
Q1 2021 Feb 08, 2022	BUY	$24.52 - $40.23 $10,053 - $16,494	410 New	410 $16,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.